Urotronic's Drug Coated Balloon Provides Minimally-Invasive, Durable Alternative for Stricture Patients in Europe MINNEAPOLIS, Sept. 23, 2020 /PRNewswire/ -- Urotronic, Inc., a Minnesota-based medical ...

Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan. A longer duration of relief to patients ...

The Optilume device includes a balloon coated with paclitaxel. The Food and Drug Administration (FDA) has approved the Optilume ® Urethral Drug Coated Balloon (DCB) to treat patients with obstructive ...

BALTIMORE, April 25, 2023 /PRNewswire/ -- Today, the American Urological Association (AUA) released the 2023 clinical practice guideline amendment for the diagnosis and management of urethral ...

HealthDay News — A new guideline by the American Urological Association, published in The Journal of Urology, provides a clinical framework for the diagnosis and treatment of male urethral stricture.

A team of surgeons in the University College Hospital (UCH), Ibadan, led by Prof. Olayinka Shittu, has successfully performed an intricate procedure to reconstruct a urethral stricture in a ...

NICE has said that Optilume can be used in the NHS for treating recurrent bulbar urethral strictures in adults if more data is collected on how well it works in the long term. Optilume is a balloon ...

NICE commissioned an external assessment centre (EAC) to review the evidence submitted by the company. This section summarises that review. Full details of all the evidence are in the project ...